Organon & Co. (OGN)

13.42 -0.04 (-0.30%) USD  |  NYSE  |  May 21, 16:00
13.42 0.00 (0.00%) Pre-Market: 19:59
More

Organon Research and Development Expense (TTM) : 363.00M for March 31, 2026

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for OGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Merck & Co., Inc. 21.57B
Eli Lilly & Co. 14.11B
Ligand Pharmaceuticals, Inc. 33.24M
Veradermics, Inc. 55.51M
Johnson & Johnson 14.99B